Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1423053 MIAMI, FL
Back to INO Full portfolio

Position in INO

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$265,952
-$232,300 QoQ
Shares Held
241,775
-15.6% QoQ
Ownership
0.234%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 101 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Derivatives in INO

reported options exposure · as of Jun 30, 2026
CallValue
$351,450
CallShares
319,500
PutValue
$92,620
PutShares
84,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. INO ranks #299 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in INO

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $351,450 319,500
2026-06-30 $265,952 241,775
2026-06-30 $92,620 84,200
2026-03-31 $128,064 73,600
2026-03-31 $498,252 286,352
2026-03-31 $107,706 61,900
2025-12-31 $78,126 44,900
2025-12-31 $668,508 384,200
2025-09-30 $25,974 11,100
2025-09-30 $281,970 120,500
2025-09-30 $29,020 12,402
2025-06-30 $133,416 65,400
2025-06-30 $49,164 24,100
2025-06-30 $344,669 168,956
2025-03-31 $34,882 21,400
2025-03-31 $12,551 7,700
2024-12-31 $39,762 21,728
2024-12-31 $49,702 27,160
2024-12-31 $41,797 22,840
2024-09-30 $81,382 14,080
2024-09-30 $246,621 42,668
2024-06-30 $308,235 38,148
2024-06-30 $126,371 15,640
2024-03-31 $264,053 19,024
2024-03-31 $795,601 57,320
2023-12-31 $190,637 373,800
2023-12-31 $16,319 32,000
2023-09-30 $10,490 26,900
2023-09-30 $129,635 332,400
2023-06-30 $163,439 363,200
2023-06-30 $8,819 19,600
2023-03-31 $309,303 377,200
2023-03-31 $97,579 119,000
2023-03-31 $788,440 961,513
2022-12-31 $814,631 522,200
2022-12-31 $733,823 470,400
2022-12-31 $313,938 201,243
2022-09-30 $1,777,071 1,027,209
2022-09-30 $1,148,027 663,600
2022-09-30 $1,008,416 582,900
2022-06-30 $961,706 555,900
2022-06-30 $984,369 569,000
2022-06-30 $591,639 341,988
2022-03-31 $673,842 187,700
2022-03-31 $938,784 261,500
2022-03-31 $558,478 155,565
2021-12-31 $2,160,170 432,900
2021-12-31 $4,436,543 889,087
2021-12-31 $3,809,864 763,500
2021-09-30 $5,730,863 800,400